NGFR and Alzheimer disease: To determine whether Ngfr signaling would alter AD-related proteins that cannot be identified by transcriptomics, we performed spatial proteomics on mCherry-enriched regions of Lv13 and Lv16-transduced SGZs in wild type and APP/PS1dE9 AD model (Fig. 5a).